FDA approves a higher dose of weight-loss drug, Wegovy
Digest more
Your doctor will help you decide which form, pill or injection, of Wegovy is best for you. It may depend on your medical history, which dosing schedule fits your lifestyle better, and how comfortable you are with needles. The best choice often depends on ...
On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, Wegovy was only available as a self-injection taken once a week
(Competitive Insight/Unsplash) While GLP-1 drugs such as Wegovy and Ozempic are now being broadly championed and widely used, several studies are revealing some potentially worrying side effects – including new research that looks in detail at related vision loss.